Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CGP 37849 is an NMDA receptor antagonist (Ki = 220 nM).1 It decreases the number of seizures induced by maximal electroshock (MES) in rats (ED50 = 21 mg/kg). CGP 37849 (0.62, 1.25, or 2.5 mg/kg) reduces immobility time in the forced swim test.2
WARNING This product is not for human or veterinary use.
1. CGP 37849 and CGP 39551: Novel and potent competitive N-
2. USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-